On Monday, Relay Therapeutics Inc (NASDAQ: RLAY) opened higher 8.63% from the last session, before settling in for the closing price of $3.36. Price fluctuations for RLAY have ranged from $1.77 to $10.72 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -23.05% over the past five years. Company’s average yearly earnings per share was noted 15.98% at the time writing. With a float of $129.41 million, this company’s outstanding shares have now reached $170.48 million.
Let’s look at the performance matrix of the company that is accounted for 261 employees. In terms of profitability, gross margin is -12.15%, operating margin of -4927.05%, and the pretax margin is -4341.53%.
Relay Therapeutics Inc (RLAY) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Relay Therapeutics Inc is 24.52%, while institutional ownership is 82.97%. The most recent insider transaction that took place on Jul 29 ’25, was worth 57,864. In this transaction an insider of this company sold 15,724 shares at a rate of $3.68, taking the stock ownership to the 377,998 shares. Before that another transaction happened on Jul 28 ’25, when Company’s insider sold 1,359 for $3.74, making the entire transaction worth $5,083. This insider now owns 393,722 shares in total.
Relay Therapeutics Inc (RLAY) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 15.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.39% during the next five years compared to -23.05% drop over the previous five years of trading.
Relay Therapeutics Inc (NASDAQ: RLAY) Trading Performance Indicators
Check out the current performance indicators for Relay Therapeutics Inc (RLAY). In the past quarter, the stock posted a quick ratio of 19.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 81.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.23, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -1.85 in one year’s time.
Technical Analysis of Relay Therapeutics Inc (RLAY)
Relay Therapeutics Inc (NASDAQ: RLAY) saw its 5-day average volume 2.89 million, a positive change from its year-to-date volume of 2.33 million. As of the previous 9 days, the stock’s Stochastic %D was 19.47%.
During the past 100 days, Relay Therapeutics Inc’s (RLAY) raw stochastic average was set at 85.45%, which indicates a significant increase from 48.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was lower than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.41, while its 200-day Moving Average is $3.95.
